维普中文期刊产品整合服务
49篇 您的检索式:作者名="Pfutzner M"
    题名 作者 年代 出处 被引量
1Saxagliptia given in combination with metformin as initial therapy im- proves glycaemic control in patients with type 2 diabetes com- pared with either monotherapy: a randomized controlled trial 显示文摘Jadzinsky M Pfutzner A Paz-Pacheco E 2009Diabetes Obes Metab2009,11,6:1
2Anti-inflammatory effects of plo-glitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the P1OSTAT Study 显示文摘Hanefeld M Marx N Pfutzner A 2007J Am Coll Cardiol2007,49,3:1
3Evaluation of a systemic antibiotic treatment of toxic puerperal metritis in dairy cows显示文摘 Beetz O Pfutzner A 2001J Dairy Sci2001,84,:1
4Saxagliptin given in combination with metformin as initial therapy improves gtycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial 显示文摘Jadzinsky M Pfutzner A Paz-Pacheco E 2009Diabetes Obes Metab2009,11,6:1
5Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2:effects on endothelial and vascular dysfunction beyond glycemic control显示文摘Forst T Weber M M Pfutzner A 2012Experimental Diabetes Research2012,2012,63:1
6Saxagliptin given in combination with metformin as initial therapy improves glycemic control in patiens with type 2 diabetes compared with either monotherapy:a randomized controlled trail显示文摘Jaczinsky M pfutzner A Paz-Pacheco E 2009Diabetes Obes Metab2009,63,:1
7Saxagliptingiven in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy:A randomized controlled trial显示文摘Jadzinsky M Pfutzner A Paz-Pacheco E 0,,06:1
8Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovas- cular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT study 显示文摘Hanefeld M Marx N Pfutzner A 2007J Am Coil Cardiol2007,49,3:1
9Saxagliptin given in combination with metformin as initial therapy improves glycaemic con- trol in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial显示文摘Jadzinsky M Pfutzner A Paz-Pacheco E 2009Diabetes Obesity and Metabolism2009,11,6:1
10Saxagliptin given incombination with metformin as initial therapy improves glycaemiccontrol in patients with type 2 diabetes compared with eithermonotherapy: a randomized controlled trial 显示文摘Jadzinsky M Pfutzner A Paz-Pacheco E 2009Diabetes Obesity andMetabolism2009,11,6:1
11Visfatin:a putative biomarker for metabolic syndrome is not influenced by pioglita-zone or simvastatin treatment in nondiabetic patients at cardiovascular risk-results from the PIOSTAT study显示文摘Pfutzner A Hanefeld M Lubben G 2007Horm Metab Res2007,39,10:1
12tlighsensiiivity C-reaetive protein predicts cardiovascular risk in diabetic and nondi- abetic patients: effects of insulinsensitizing treatment with piogli|szone 显示文摘PFUTZNER A SCttONDORF T HANEFELD M 2010J Diabetes Sci Technol2010,4,8:1
13First evidencefor the two-proton decay of 45Fe显示文摘Pfutzner M Badura E Bingham C 2002European PhysicalJournal A2002,14,:1
14Radioactivedecays at limits of nuclear stability 显示文摘Pfutzner M Kamy M Grigorenko L V 2012Reviews ofModem Physics2012,84,:1
15Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein:the PIOSTAT Study显示文摘Hanefeld M Marx N Pfutzner A 2007J Am Coll Cardiol2007,49,3:1
16High sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone显示文摘Pfutzner A Schondorf T Hanefeld M 2010J Diabetes Sci Technol2010,4,3:1
17Intact and total proinsulin:new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance显示文摘Pfutzner A Pfutzner AH Larbig M 0,,:1
18Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial显示文摘Jadzinsky M Pfutzner A Paz-Pacheco E 2009Diabetes Obes Metab2009,11,6:1
19Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance 显示文摘Pfutzner A Langenfeld M Kunt T 2003Clin Lab2003,49,:1
20Anti-i nflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study显示文摘Hanefeld M Marx N Pfutzner A 2007JAm Coll Cardiol2007,49,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费